Carerx Corp Stock Total Debt
| CRRX Stock | CAD 2.76 0.16 6.15% |
CareRx Corp fundamentals help investors to digest information that contributes to CareRx Corp's financial success or failures. It also enables traders to predict the movement of CareRx Stock. The fundamental analysis module provides a way to measure CareRx Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx Corp stock.
As of the 21st of March 2025, Total Debt To Capitalization is likely to grow to 0.63. CareRx | Total Debt |
CareRx Corp Company Total Debt Analysis
CareRx Corp's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current CareRx Corp Total Debt | 5.33 M |
Most of CareRx Corp's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CareRx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CareRx Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for CareRx Corp is extremely important. It helps to project a fair market value of CareRx Stock properly, considering its historical fundamentals such as Total Debt. Since CareRx Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CareRx Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CareRx Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
CareRx Net Debt
Net Debt |
|
Based on the latest financial disclosure, CareRx Corp has a Total Debt of 5.33 M. This is 99.81% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total debt for all Canada stocks is 99.9% higher than that of the company.
CareRx Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareRx Corp's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CareRx Corp could also be used in its relative valuation, which is a method of valuing CareRx Corp by comparing valuation metrics of similar companies.CareRx Corp is currently under evaluation in total debt category among its peers.
CareRx Fundamentals
| Return On Equity | -0.0543 | ||||
| Return On Asset | 0.0186 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 235.15 M | ||||
| Shares Outstanding | 62.15 M | ||||
| Shares Owned By Insiders | 10.35 % | ||||
| Shares Owned By Institutions | 28.05 % | ||||
| Number Of Shares Shorted | 26.34 K | ||||
| Price To Book | 1.92 X | ||||
| Price To Sales | 0.44 X | ||||
| Revenue | 366.71 M | ||||
| Gross Profit | 108.06 M | ||||
| EBITDA | 22.06 M | ||||
| Net Income | (4.5 M) | ||||
| Cash And Equivalents | 28.37 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 5.33 M | ||||
| Debt To Equity | 2.35 % | ||||
| Current Ratio | 1.69 X | ||||
| Book Value Per Share | 1.35 X | ||||
| Cash Flow From Operations | 37.99 M | ||||
| Short Ratio | 1.53 X | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 3.73 | ||||
| Number Of Employees | 1.42 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 161.6 M | ||||
| Total Asset | 223.54 M | ||||
| Retained Earnings | (287.19 M) | ||||
| Working Capital | (467 K) | ||||
| Net Asset | 223.54 M |
About CareRx Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.